J 2025

Implementation of a New Surgical Technique in a Gynecologic Oncology Centre: Sentinel Lymph Node Biopsy and Its Learning Curve in Endometrial Cancer

KOBLÍŽKOVÁ, Michaela; Petra BRETOVÁ; Luboš MINÁŘ; Michal FELSINGER; Branislav BABJAK et al.

Základní údaje

Originální název

Implementation of a New Surgical Technique in a Gynecologic Oncology Centre: Sentinel Lymph Node Biopsy and Its Learning Curve in Endometrial Cancer

Vydání

Cancers, Basels, MDPI, 2025, 2072-6694

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.400 v roce 2024

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/25:00142941

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

sentinel lymph node biopsy; endometrial cancer; learning curve; surgical technique implementation; gynecologic oncology

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 18. 2. 2026 13:02, Mgr. Tereza Miškechová

Anotace

V originále

Sentinel lymph node biopsy (SLNB) enables precise evaluation of lymphatic spread in endometrial cancer, reducing the requirement for extensive surgical procedures. This study examined how surgeons at University Hospital Brno acquired the skills to perform this technique and identified the factors that influenced their success. Between 2019 and 2024, 337 women with endometrial cancer underwent hysterectomy with SLNB. The rate of successful lymph node detection increased with surgical experience and supervision. Surgeons achieved stable and high detection rates after about 30 procedures. Lower detection was observed in patients with fibroids or adenomyosis, conditions that can make mapping more difficult. The study shows that structured training and expert mentorship help surgeons master SLNB more efficiently. Extending supervised training to 30–35 procedures maintains accuracy and supports consistent, high-quality care for women with endometrial cancer.